Yair Reisner

Affiliations: 
IMM Immunology Weizmann Institute of Science, Rehovot, Israel 
Area:
Immunology, Cell Biology
Google:
"Yair Reisner"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bachar-Lustig BE, Lask A, Eidelstein Y, et al. (2023) Generation of non-alloreactive anti-viral central memory CD8 human veto T cells for cell therapy. Transplantation and Cellular Therapy
Sidlik Muskatel R, Nathansohn-Levi B, Reich-Zeliger S, et al. (2023) Correction of T-Cell Repertoire and Autoimmune Diabetes in NOD Mice by Non-myeloablative T-Cell Depleted Allogeneic HSCT. Stem Cells Translational Medicine. 12: 281-292
Singh AK, Schetzen E, Yadav SK, et al. (2021) Correction of murine sickle cell disease by allogeneic haematopoietic cell transplantation with anti-3rd party veto cells. Bone Marrow Transplantation
Sidlik-Muskatel R, Reisner Y. (2019) Toward safer haploidnetical hematopoietic stem cell transplantation. Bone Marrow Transplantation. 54: 733-737
Reisner Y, Or-Geva N. (2019) Veto cells for safer nonmyeloablative haploidentical HSCT and CAR T cell therapy. Seminars in Hematology. 56: 173-182
Singh AK, Schetzen E, Lustig EB, et al. (2019) Proof of Concept for Repair of Sickle Cell Disease By Non-Myeloablative MHC Disparate T Cell Depleted HSCT Combined with Donor-Derived Veto Cells Blood. 134: 1919-1919
Al Malki M, Jones R, Ma Q, et al. (2018) Proceedings From the Fourth Haploidentical Stem Cell Transplantation Symposium - HAPLO2016, San Diego, California, December 1, 2016. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation
Milman Krentsis I, Rosen C, Shezen E, et al. (2018) Lung Injury Repair by Transplantation of Adult Lung Cells Following Preconditioning of Recipient Mice. Stem Cells Translational Medicine. 7: 68-77
Aversa F, Bachar-Lustig E, Or-Geva N, et al. (2017) Immune tolerance induction by nonmyeloablative haploidentical HSCT combining T-cell depletion and posttransplant cyclophosphamide. Blood Advances. 1: 2166-2175
Or-Geva N, Gidron-Budovsky R, Radomir L, et al. (2017) Towards 'off-the-shelf' genetically modified T-Cells: Prolonging functional engraftment in mice by CD8 veto T-cells. Leukemia
See more...